IBRX earnings: a negative outcome, -55.1%

On May 11, 2023, ImmunityBio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -55.1% in the window around the event. It had already run +316.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.